) Shawnee operates her own financial advisory firm, overseeing clients' assets. Shes also your employer. As her analyst, you're on a $75k annual salary. Interestingly, she also benefits from a free OpenAI's ChatGPT subscription. Currently, Shawnee is contemplating a significant investment in the pharmaceutical sector. However, she's uncertain about the industrys profitability. Seeking clarity, she requests a 5-Forces analysis on the industry. To this end, she poses a query to ChatGPT: "Offer a comprehensive five forces analysis on the pharmaceutical sector." The response from ChatGPT is available under "Appendix I" at the document's conclusion. Impressed by ChatGPT's insights, Shawnee deliberates replacing you with the AI tool. Your task? Validate your worth. Make your employer understand that you are not replaceable by ChatGPT. Perform the following: 1. Conduct your own 5 forces analysis on the pharmaceutical industry. Your analysis should outshine ChatGPT's in terms of depth and detail. If it doesn't, Shawnee might terminate your employment. 2. Subsequent to your analysis, contemplate integrating the ensuing discussion points to strengthen your stance: i. Point out any shortcomings in ChatGPT's response, if any. ii. Identify errors within ChatGPT's answer, if any. iii. Go above and beyond. (Hint: Perhaps ChatGPT's conclusion lacked depth? Can you enhance this aspect?) 4. a. Define business model. (Limit: 2 sentences.) (5 pts) b. Why is the subscription model becoming more popular? (5 pts) Appendix I Shawnee: Complete a five forces analysis on pharmaceutical industry. Be as detailed as you can. ChatGPT: The pharmaceutical industry is a highly competitive sector that is impacted by various forces that can affect profitability and market share. A comprehensive five forces analysis of the pharmaceutical industry is presented below: 1. Threat of New Entrants: The pharmaceutical industry is characterized by high barriers to entry, which makes it difficult for new companies to enter the market. The cost of research and development, clinical trials, and regulatory compliance is very high. Additionally, the industry is highly regulated, and the regulatory approval process is time-consuming and costly. As a result, new companies face significant challenges in entering the market, making the threat of new entrants relatively low. 2. Bargaining Power of Suppliers: The bargaining power of suppliers in the pharmaceutical industry is low to moderate. The industry requires raw materials and active pharmaceutical ingredients (APIs) from suppliers, but the demand is usually high, which gives manufacturers some leverage. However, the suppliers of critical raw materials and APIs can exert significant power over manufacturers. Additionally, the industry is subject to supply chain disruptions, such as the shortage of critical raw materials, which can impact the bargaining power of suppliers. 3. Bargaining Power of Buyers: The bargaining power of buyers in the pharmaceutical industry is relatively high. The industry is highly competitive, and buyers can choose from a range of products and suppliers. Additionally, the availability of generic drugs and biosimilars has increased competition, which has given buyers more bargaining power. Finally, buyers, such as government agencies and insurance companies, have significant purchasing power, which allows them to negotiate lower prices. 4. Threat of Substitutes: The threat of substitutes in the pharmaceutical industry is relatively low. There are few substitutes for prescription drugs, and they are usually less effective or have more severe side effects. However, the availability of generic drugs and biosimilars has increased competition, which can impact market share and profitability for brand-name drugs. 5. Intensity of Competitive Rivalry: The pharmaceutical industry is highly competitive, with a few dominant players and many smaller companies. The industry is characterized by high levels of research and development spending, marketing and advertising efforts, and intellectual property rights protection. As a result, the industry is subject to intense competition, which can impact market share and profitability for individual companies. The industry is also subject to significant regulatory and legal risks, including patent litigation and regulatory challenges. Overall, the pharmaceutical industry is subject to a range of forces that impact profitability and market share. Companies must navigate these forces while also investing in research and development, regulatory compliance, and marketing efforts to succeed in the industry